Triflusal for preventing serious vascular events in people at high risk

Stroke

Volumn 37, Issue 8, 2006, Pages 2193-2195

  Costa, João ^a   Ferro, José M ^a   Matías Guiu, Jordi ^b   Alvarez Sabin, José ^c   Torres, Ferran ^c,d  

^a HOSPITAL DE SANTA MARIA   (Portugal)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

Cerebrovascular disorders; Meta analysis; Platelet aggregation inhibitors

Indexed keywords

ACETYLSALICYLIC ACID; TRIFLUSAL;

ACUTE HEART INFARCTION; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HIGH RISK POPULATION; HUMAN; PRIORITY JOURNAL; STROKE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

EID: 33748196552     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000231642.59626.74     Document Type: Article

References (1)

1. Costa J, Ferro JM, Matias-Guiu J, Alvarez-Sabin J, Torres F. Triusal for preventing serious vascular events in people at high risk. The Cochrane Database of Systematic Reviews. 2005;3: Art. No.: CD004296.pub2. DOI: 10.1002/14651858.CD004296.pub2.